A pivotal phase 3 study to evaluate WTX101 in patients with Wilson Disease.
Phase of Trial: Phase III
Latest Information Update: 10 Dec 2016
At a glance
- Drugs Bis-choline tetrathiomolybdate (Primary)
- Indications Hepatolenticular degeneration
- Focus Therapeutic Use
- 10 Dec 2016 According to Wilson Therapeutics media release, company is planning to initiate the study in 2017.
- 10 Dec 2016 New trial record